Background-The short-QT syndrome is a new clinical entity characterized by corrected QT intervals Ͻ300 ms and a high incidence of ventricular tachycardia (VT) and fibrillation (VF). Gain-of-function mutations in the gene for outward potassium currents have been shown to underlie the congenital syndrome. The present study examined the cellular basis of VT/VF in an experimental model associated with short QT intervals created with a potassium channel activator. Methods and Results-Transmembrane action potentials from epicardial and M regions, 4 transmural unipolar electrograms, and a pseudo-ECG were simultaneously recorded in canine arterially perfused left ventricular wedge preparations. At a basic cycle length of 2000 ms, pinacidil (2 to 3 mol/L) abbreviated the QT interval from 303.7Ϯ5.4 to 247.3Ϯ6.9 ms (meanϮSEM, PϽ0.0001). The maximal transmural dispersion of repolarization (TDR max ) increased from 27.0Ϯ3.8 to 64.9Ϯ9.2 ms (PϽ0.01), and an S2 applied to the endocardium induced a polymorphic VT (pVT) in 9 of 12 wedge preparations (PϽ0.01). Addition of isoproterenol (100 nmol/L, nϭ5) led to greater abbreviation of the QT interval, a further increase in TDR max (from 55.4Ϯ13.7 to 69.7Ϯ8.3 ms), and more enduring pVT. TDR max was correlated significantly with the T peak -T end interval under all conditions. The effects of pinacidil were completely reversed by glybenclamide (10 mol/L, nϭ4) and partially reversed by E4031 (5 mol/L, nϭ5), which prevented induction of pVT in 3 of 5 preparations. 
T he short-QT syndrome is a relatively new clinical entity characterized by short QT intervals in the ECG, the absence of structural heart disease, a familial history of sudden cardiac death, and major (resuscitated cardiac arrest, syncope) or minor (palpitations, dizziness, atrial fibrillation) arrhythmic events. [1] [2] [3] [4] [5] [6] From a theoretical point of view, the shortening of ventricular repolarization can be the consequence of either an increase in repolarizing currents or a decrease in depolarizing currents during the plateau and/or phase 3 of repolarization. Our group recently described the first mutation associated with the short-QT syndrome. 5 A missense mutation involving a substitution of lysine for asparagine in position 588 of HERG (KCNH2) was found to cause a remarkable gain of function in the rapidly activating delayed rectifier current, I Kr .
A distinctive ECG feature of the short-QT syndrome is the development of tall, peaked, symmetrical T waves and relatively long T peak -T end intervals, indicative of augmented transmural dispersion of repolarization (TDR). Previous studies involving the canine arterially perfused wedge preparation have demonstrated the arrhythmogenic role of increased TDR under long-QT conditions as well as in the Brugada syndrome. [7] [8] [9] [10] [11] [12] In this study, we made use of the canine left ventricular (LV) wedge preparation to test the hypothesis that abbreviation of the QT interval is associated with an increase in TDR, which creates the substrate for reentry responsible for the development of life-threatening ventricular tachycardia/fibrillation (VT/VF). Because an I Kr activator is unavailable, we chose to use the ATP-sensitive potassium current (I K-ATP ) activator pinacidil to augment outward currents.
Methods
Adult (ie, Ͼ1 year old) male dogs weighing 20 to 25 kg were anticoagulated with heparin and anesthetized with sodium pentobarbital (30 to 35 mg/kg IV). The chest was opened via a left thoracotomy, and the heart was excised, placed in Tyrode's solution, and transferred to a dissection tray. Transmural LV wedges with dimensions of Ϸ12ϫ25ϫ12 mm were dissected from the mid-toapical anterior region of the LV wall, and a diagonal branch of the left anterior descending coronary artery was cannulated and perfused with Tyrode's solution. The composition of the Tyrode's solution was (in mmol/L) as follows: NaCl 129, KCl 4, NaH 2 PO 4 0.9, NaHCO 3 The ventricular-wedge preparations were allowed to equilibrate in the chamber for 2 hours while being paced at basic cycle lengths (BCLs) of 2000 ms with Ag bipolar electrodes placed in contact with the endocardial surface. The temperature of the perfusate was maintained at 35°C.
Transmembrane action potentials were recorded from the epicardial surface and subendocardial M-cell regions by using floating microelectrodes. Four transmural, unipolar electrograms were recorded and used to measure activation recovery intervals (ARIs). ARI1 was recorded from the subendocardium, ARI4 was recorded from the subepicardium, and ARI2 and ARI3 were equally spaced within the midmyocardium. Each unipolar recording was differentiated, and the ARI approximating the action potential duration (APD) at each site was measured as the interval between the time of the minimum first derivative (V min ) of the QRS deflection and the maximum first derivative (V max ) of the T wave. The repolarization time (RT) was defined as ARIϩactivation time (from stimulus artifact to V min ). The absolute value of the maximal RT difference was considered as the maximal transmural dispersion of repolarization (TDR max ). A transmural pseudo-ECG was recorded by using 2 AgCl half-cells placed Ϸ1 cm from the epicardial (ϩ) and endocardial (Ϫ) surfaces of the preparation and along the same axis as the transmembrane and unipolar recordings. T peak -T end was measured from the peak to the end of the T wave in the case of an upright T wave and from the nadir to the end of the T wave in the case of a negative T wave.
After control recordings were obtained, pinacidil (2 to 3 mol/L) was added to the coronary perfusate alone or in association with either isoproterenol (100 nmol/L), E4031 (5 mol/L), or glybenclamide (10 mol/L). Experiments were performed in 12 different hearts. Control and pinacidil (2 to 3 mol/L) conditions were tested in 12 experiments. Isoproterenol (100 nmol/L) was added to pinacidil in 5 experiments. Glybenclamide (10 mol/L) was added to pinacidil in 4 experiments (in 1 experiment after isoproterenol washout). E4031 (5 mol/L) was added to pinacidil in 5 experiments (in 1 experiment after isoproterenol washout) All measured values returned to preisoproterenol values after isoproterenol washout.
VT inducibility was examined under each condition (control, drugs, BCL 600 ms, and BCL 2000 ms). An S2 extrastimulus was applied starting at an S1-S2 coupling interval equivalent to the longest APD recorded, decreasing in 10-ms steps until the refractory period was reached.
Statistics
Summary data are reported as meanϮSEM. Statistical analysis was performed with a paired t test for the 12 replicates recorded under control conditions and after pinacidil. We used Friedman's test for the 3 secondary experiments (pinacidil plus isoproterenol, glybenclamide, or E4031). Proportions were compared with McNemar's test for paired data.
Results
Differences in the time course of repolarization of the epicardial and M-cell regions of the LV wall are responsible for the inscription of the ECG T wave and the normal and pathophysiological characteristics of the TDR. These characteristics of the LV wall are illustrated in Figure 1 . Each panel shows transmembrane action potentials simultaneously recorded from the epicardial and deep subendocardial M-cell regions of the arterially perfused LV wedge preparation, together with 4 unipolar electrodes and an ECG. The QT interval was 313 ms and the TDR was 41 ms under control conditions. Figure 1B was recorded after the activation of I K-ATP by pinacidil (2 mol/L). Pinacidil produced a preferential abbreviation of the M-cell action potential, leading to abbreviation of the QT interval (213 ms), inversion of the T wave due to repolarization of the epicardium after the M region, and amplification of the TDR to 67 ms. The addition of isoproterenol (100 nmol/L) produced a further abbreviation of the QT interval to 195 ms and an augmentation of the TDR to 92 ms. Figure 2 illustrates the dose-dependent effect of pinacidil on the QT interval and TDR. Pinacidil produced a dosedependent abbreviation of QT but a prolongation of TDR. Programmed electrical stimulation (S2 applied to the endocardium) failed to induce VT either under control conditions or after 1 or 2 mol/L pinacidil but succeeded in precipitating polymorphic ventricular tachycardia (pVT) after 3 mol/L pinacidil. TDR max increased to 79 ms at the highest concentration of pinacidil.
In 12 replicate experiments, 2 to 3 mol/L pinacidil abbreviated the QT interval from 303.7Ϯ5.4 to 247.3Ϯ6.9 ms (PϽ0.0001). TDR max increased from 27.0Ϯ3.8 to 64.9Ϯ9.2 ms (PϽ0.01) as a result of a greater abbreviation of ARI1 or ARI2 versus ARI3 or ARI4 (maximum abbreviation: ARI1 or ARI2, 90.8Ϯ26.2 ms; ARI3 or ARI4, 61.5Ϯ17.8 ms; PϽ0.05). Conduction, as assessed by the time interval between the stimulus artifact and the V min of the epicardial electrogram, did not change after pinacidil (32.6Ϯ1.69 versus 33.8Ϯ2.07 ms under control conditions). Arrhythmia was never inducible under control conditions. After pinacidil (2 to 3 mol/L), pVT was induced in 9 of 12 preparations (PϽ0.01). Figure 3 illustrates the response of individual experimental preparations to pinacidil-induced TDR max and pVT. The 3 preparations in which pVT could not be induced were those that exhibited the smallest increase in TDR max . Programmed electrical stimulation induced pVT in all preparations in which TDR max was increased to values Ͼ40 ms.
The QT-interval abbreviation unaccompanied by an increase in TDR was not sufficient to induce pVT. Reduction of the BCL to 600 ms abbreviated the QT interval under control conditions to values similar to those obtained with pinacidil at a BCL of 2000 ms (242.4Ϯ3.8 versus 247.3Ϯ6.9 ms). TDR max under these conditions reached 39.7Ϯ3.7 ms and pVT was not inducible, suggesting that QT abbreviation alone was not enough to permit the induction of pVT.
Induction of VT/VF in other sudden death syndromes, including catecholaminergic VT and the long-QT syndrome, is facilitated by exercise and other sympathetic stimuli. In another series of experiments, we examined the influence of ␤-adrenergic stimulation in the form of isoproterenol. Figure  4 illustrates the effect of isoproterenol on arrhythmogenicity in this experimental. The QT interval and TDR were 313 and 41 ms, respectively, under control conditions and 213 and 67 ms, respectively, after 2 mol/L pinacidil. Programmed electrical stimulation (S1-S2ϭ150 ms) induced a brief episode of pVT. The addition of isoproterenol (100 nmol/L) led to a further abbreviation of the QT interval (195 ms), a further increase of TDR max (92 ms), and a more enduring pVT (precipitated at an S1-S2 of 110 ms). Figure 5 and the Table summarize the results of 5 similar experiments. VT could not be induced under control conditions. With pinacidil alone, pVT was induced in 3 of 5 preparations. After the addition of isoproterenol, pVT was induced in 5 of 5 preparations. Figure 6 displays the relation between TDR max , the T peak -T end interval, and the susceptibility to induced pVT. The correlation between TDR max and the T peak -T end interval was significant 
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(TDR max ϭ1.05ϫ[T peak -T end ]Ϫ3, R 2 ϭ0.73, PϽ0.0001). The inducibility of pVT was consistently associated with a critical TDR max Ͼ50 ms.
Glybenclamide completely reversed the effects of pinacidil on ARI, TDR max , and T peak -T end (Table, nϭ4 ) and prevented pVT in 4 of 4 preparations in which pinacidil induced the arrhythmia. E4031 partially reversed the effects of pinacidil on ventricular repolarization duration and TDR max (Table,  nϭ5 ). E4031 prevented pVT in 4 of 4 preparations in which pinacidil induced the arrhythmia at a BCL of 2000 ms. At a BCL of 600 ms, E4031 prevented pVT in only 2 of the 4 preparations that were inducible after pinacidil at a BCL of 2000 ms.
Discussion
Our study presents the first experimental evidence of the role of transmural dispersion of repolarization in arrhythmogenesis associated with short QT intervals in the ECG. Pinacidil was used to mimic a gain of function of a potassium current in the canine arterially perfused wedge preparation, a preparation that has been successfully used to reproduce the electrocardiographic and arrhythmic manifestation of the long-QT syndrome, Brugada syndrome, and catecholaminergic VT. 13, 14 Our principal findings are that activation of I K-ATP with pinacidil abbreviates APD, increases transmural dispersion of repolarization, and thus creates the substrate for the induction of pVT. Arrhythmogenicity is enhanced by isoproterenol and completely reversed by glybenclamide but not entirely by the I Kr blocker E4031.
Pinacidil activates I K-ATP , leading to an abbreviation of APD. 15, 16 In the wedge preparation, pinacidil abbreviates the QT interval by 20%, leading to a heterogeneous abbreviation of the APD of the 3 principal cell types spanning the ventricular wall. A preferential effect of pinacidil to cause loss of the action potential dome and thus, to abbreviate epicardial APD in the right ventricle has been shown to contribute to the development of the substrate for the Brugada syndrome. The prominence of the transient outward current (I to ) underlies the greater response to pinacidil in the right ventricle. 12, 17, 18 A similar phenomenon is not observed in the LV, which is known to possess a weaker I to . Pinacidil induced a preferential abbreviation of the LV M cells located in the deep subendocardium. The ionic basis for this preferential abbreviation of the M-cell APD is unknown. One hypothesis is that this is a consequence of a nonuniform density of I K-ATP or other currents or exchangers across the ventricular wall. The heterogeneous response to pinacidil observed in our experimental series is inconsistent with a greater role for I K-ATP in epicardium versus endocardium, as has been suggested for the feline heart. 19 Although previous studies have shown that pinacidil facilitates the induction of VF under both normoxic conditions and conditions of ischemia/reperfusion, 20, 21 relatively little information regarding the mechanism of its arrhythmogenesis has been provided. Abbreviation of the effective refractory period by I K-ATP openers has been shown to increase ventricular vulnerability to reentry and to accelerate its rate in a model of VF in superfused canine right ventricular epicardial slices. 22 Our results indicate that pinacidil-induced abbreviation of repolarization in the LV is associated with an increased TDR, a well-known substrate for the development of pVT. Although the abbreviated wavelength (product of effective refractory period and conduction velocity) expected under these conditions is insufficient by itself to form the substrate for reentry, this action of the drug does serve to reduce the threshold at which TDR can permit pVT to Ϸ50 ms. It is noteworthy that under long-QT conditions, this value is Ϸ90 ms in the LV wedge preparation. 13, 23 Pinacidil is a specific activator of the I K-ATP channel. Pinacidil's effects on APD, ARI, and TDR were all reversed by glybenclamide, suggesting that these actions of the drug are largely attributable to I K-ATP activation, despite the fact that glybenclamide is not a specific inhibitor of I K-ATP . The variability in drug potency to abbreviate the APD and increase the TDR in different preparations may be due to breed-or age-related differences in the sensitivity of the I K-ATP channel or to intrinsic differences in net repolarizing current.
Effect of Pinacidil Alone and in Association With
Isoproterenol was found to amplify the actions of pinacidil to preferentially abbreviate the M-cell APD. Among its many actions, isoproterenol increases slowly activating delayed rectifier current (I Ks ) and in the absence of pinacidil produces a greater abbreviation of the epicardial and endocardial action potential, where I Ks is relatively large. 24, 25 The greater abbreviation of the M-cell APD in the presence of pinacidil may be secondary to cAMP-mediated phosphorylation of the I K-ATP channel, 16 leading to potentiation of the action of pinacidil. This potentiation of I K-ATP activation by isoproterenol may underlie the effect of catecholamines to increase the risk of life-threatening arrhythmias under ischemic conditions and may contribute to the protective effect of ␤-blockers. 26, 27 The I Kr blocker E4031 partially reversed the effect of pinacidil. pVT could still be induced at a BCL of 2000 ms in 1 preparation and at a BCL of 600 ms in 2 additional preparations. The lack of protection of E4031 at the faster pacing rate may be due to the well-known reverse ratedependent prolongation of APD observed with most I Kr blockers. 28 We found a good association between the level of TDR max and the inducibility of pVT. The critical role of TDR as a substrate for functional reentry has been demonstrated in models of prolonged repolarization (congenital and acquired long-QT syndrome, [7] [8] [9] 29 hypertrophy, 30 and heart failure). 31 In addition, epicardial and transmural dispersion of repolarization seems also to be a key mechanism of arrhythmias in the Brugada syndrome. 10 -12 To the best of our knowledge, this is the first demonstration of a role for transmural heterogeneity of repolarization under conditions associated with short QT intervals in the ECG.
The pinacidil model of the short-QT syndrome, although mechanistically related, is phenotypically different from the clinical syndrome caused by a gain of function of HERG (SQT1), the gene that encodes I Kr , 5 or the short-QT syndrome recently described by Bellocq and coworkers 32 and shown to be due to a gain of function in KCNQ1 (SQT2), the gene that encodes for I Ks . In these 2 syndromes, the ECG of affected individuals often manifests tall, peaked, symmetrical T waves rather than inverted T waves, as predicted by the present model involving activation of I K-ATP . The prolonged T peak -T end observed in SQT1 and SQT2 points to a prolonged TDR as the arrhythmogenic substrate. Thus, the present model is consistent with the known clinical phenotypes, in that abbreviation of the QT interval is associated with a very significant accentuation of TDR. In a review of the short-QT syndrome in 2002, we suggested I Kr and I Ks as 2 of our 4 principal gene candidates. 2 The other 2 were I K-ATP and acetylcholineactivated potassium current. The wedge model also mimics the clinical syndrome in its ability to develop pVT in response to programmed electrical stimulation. Although both pVT and monomorphic VT have been reported to be associated with the short-QT syndrome, 33 we have not as yet observed monomorphic VT in the wedge. Our data provide an important proof of concept relative to the role of TDR in arrhythmogenesis under conditions associated with premature repolarization of the ventricles and short QT intervals. It is tempting to speculate that this mechanism may play a role in the development of the short, coupled variant of torsade de pointes as well as ischemia-induced arrhythmias, because I K-ATP activation is an important component of ischemia. Potassium channel activators have been proposed as potential antiarrhythmic agents in the long-QT syndrome. Our data suggest a potential proarrhythmic effect of I K-ATP activation.
